Immunocore's Tebentafusp Sole Winner In EU Fast-Track Stakes In June

European Medicines Agency's CHMP Rejected Four Out Of Five Requests

 
• By Maureen Kenny
  
The EMA will fast track its review of advanced uveal melanoma drug tebentafusp. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography